The mechanism of an endothelin-1-(ET-1-) induced intracellular Ca2+ ([
Ca2+](i)) increase and the receptor subtype(s) responsible for this ef
fect in single human melanocytes were studied using fura-2/AM. ET-1 in
duced a transient increase in [Ca2+](i) in a concentration-dependent m
anner, The transient [Ca2+](i) increase was followed by a sustained pl
ateau level of [Ca2+](i) which was higher than the initial [Ca2+](i) l
evel, IRL-1620, a specific ET-B receptor agonist, increased [Ca2+](i)
in a dose-dependent manner, BQ-788, a specific ET-B receptor antagonis
t, abolished the ET-1-induced [Ca2+](i) increase. but BQ-123, a specif
ic ET-A receptor antagonist, failed to prevent it. U73122, an inhibito
r of phospholipase C (PLC), inhibited the ET-1-induced [Ca2+](i) rise
in a dose-dependent manner, Prior depletion of intracellular Ca2+ stor
es with thapsigargin, an inhibitor of Ca2+-ATPase of the endoplasmic r
eticulum, abolished the ET-1-induced Ca2+ transient, whereas removal o
f extracellular Ca2+ with EGTA eliminated the sustained rise. These re
sults suggest that in cultured human melanocytes the binding of ET-1 t
o ET-B receptors and the subsequent activation of PLC mediate ET-1-ind
uced [Ca2+](i) increase, The transient [Ca2+](i) increase is attribute
d to mobilization of Ca2+ from inositol 1,4,5-trisphosphate-sensitive
intracellular Ca2+ stores, and the sustained [Ca2+](i) level may be re
lated to the influx of extracellular Ca2+.